Hi uboy, hopefully these comments by goolsbee will soon be prophetic
Any progression, anywhere, will require final trial results. Not long now.
But in a vicious circle, while the Sarepta drug may slow the progression of the disease it can’t stop the disease-created inflammation that keeps attacking the muscle.
The Antisense treatment is designed to treat the inflammation that exacerbates muscle fibre damage.
This can be managed by using cortico-steroids but these come with a whole range of side effects including excessive weight gain — precisely the wrong thing for boys who already have limited movement.
$$$$“What we want to do is add our treatment ATL1102 on top of that drug$$$$ and eliminate a substantial portion of continued muscle degeneration, so whatever the period of ambulation is for that boy would be longer – years is our expectation,” Mr Goolsbee said.
“We can almost create a position of stasis of the disease.”
- Forums
- ASX - By Stock
- PER
- How does ATL1102 compare with Vamorolone
How does ATL1102 compare with Vamorolone, page-8
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $85.01M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.2¢ | $103.7K | 1.237M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 280000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 0.082 |
3 | 287000 | 0.081 |
8 | 672686 | 0.080 |
6 | 413817 | 0.079 |
6 | 689399 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 280000 | 3 |
0.086 | 96543 | 1 |
0.088 | 27962 | 1 |
0.089 | 200000 | 1 |
0.090 | 604764 | 4 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |